January 02, 2026

NK-1 Drug Fills Motion Sickness Gap

Tradipitant demonstrates 50% to 70% risk reduction for vomiting incidence during motion exposure in phase 3 trials.

Conexiant

December 29, 2025

Medical Oddities: Dairy and Dementia’s New Angle

From cheese counters to tea kettles to rush hour—and even the role of romance—new studies suggest health shows up in unexpected places.

Conexiant

December 22, 2025

Long-Term Tofersen Shows Benefit in SOD1-Mutated ALS

Final data from the phase III VALOR trial and its open-label extension study showed that patients with SOD1-mutated ALS benefit from treatment with the intrathecal antisense oligonucleotide tofersen.

Conexiant

December 18, 2025

Psychiatric Genetics: Shared Risk Across Disorders

Large-scale genomic analysis of 14 psychiatric disorders identified five underlying genetic factors and biological pathways

Conexiant

December 17, 2025

Oregon Hospital Preps for the Big One

A vulnerable Oregon hospital moves fast to protect patients and neighbors after FEMA funding is abruptly cut.

KFF Health News

December 12, 2025

Nine Breakthrough Studies Define 2025 Research

From GLP-1 cardioprotection to genome sequencing in newborns, this year's top research spans critical clinical frontiers.

Conexiant

December 10, 2025

HyperCKemia and Involuntary Movements: What’s Your Diagnosis?

Routine laboratory studies were within reference ranges except for striking hyperCKemia of 1961 U/L.

Conexiant

December 09, 2025

Renal Impairment: New Dementia Clue Found 

Reduced renal function significantly alters blood biomarkers of neurodegeneration but acts as a disease modifier rather than an independent risk factor for dementia.

Conexiant

December 09, 2025

The $100K Rule No One Saw Coming

Rural hospitals warn that a sudden visa cost hike could deepen dire workforce gaps.

KFF Health News